JESÚS MARÍA
OJANGUREN BERGAZ
Forscher bis um 2022
Hospital Universitari de Girona Dr. Josep Trueta
Girona, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitari de Girona Dr. Josep Trueta (1)
2007
-
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis
Leukemia, Vol. 21, Núm. 1, pp. 143-150